GRI Bio, Inc.

US$1.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GRIHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (96.66%)
Div yield —
ROE (142.02%)
Biotechnology
Beta (5Y) (0.59)
PE TTM —
TSR TTM (96.05%)
Mkt cap US$4.110M
ROIC (88.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.15
14.16%
(74.69%)
Hold 8|7|5|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.04
0.04
0.04
11.45%
7.33%
9.50%
3.67%
Revenue$M
0.463
0.454
0.464
0.485
6.12%
6.98%
5.45%
10.28%
Peers (US$4.110M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.740
(0.382)
(0.422)
EBIT/Intx
4.173
0.414
0.425
Own earn%
22.75
143.82
145.22
Sh yield%
12.55
18.56
18.43
Owners
Insiders/Inst%
14.11
61.28
Short interest%
5.39
SBC / revenue%
3.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–18
$1 testx
0.0
Incr. ROIC%
13